NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 74 filers reported holding NEVRO CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $26,771,000 | -20.6% | 359,678 | 0.0% | 0.97% | -16.9% |
| Q1 2017 | $33,702,000 | +29.0% | 359,678 | 0.0% | 1.17% | +12.8% |
| Q4 2016 | $26,134,000 | -62.1% | 359,678 | -45.5% | 1.04% | -66.4% |
| Q3 2016 | $68,942,000 | +41.5% | 660,428 | 0.0% | 3.09% | +22.4% |
| Q2 2016 | $48,713,000 | +31.1% | 660,428 | 0.0% | 2.53% | +2.5% |
| Q1 2016 | $37,156,000 | -44.6% | 660,428 | -33.5% | 2.47% | -42.2% |
| Q4 2015 | $67,066,000 | +45.5% | 993,428 | 0.0% | 4.27% | +40.6% |
| Q3 2015 | $46,085,000 | -13.7% | 993,428 | 0.0% | 3.04% | +8.9% |
| Q2 2015 | $53,397,000 | -18.7% | 993,428 | -27.5% | 2.79% | -6.1% |
| Q1 2015 | $65,659,000 | +23.9% | 1,369,899 | 0.0% | 2.97% | +15.6% |
| Q4 2014 | $52,974,000 | – | 1,369,899 | – | 2.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |